|
Last
updated February 10, 2005
Saturday, MAY 14
8:00am–11:00am
4103—Neonatal
Immunology—Relevance to the Clinician
PAS Mini Course
Chair:
E. Richard Stiehm, Mattel Children's Hospital at UCLA, Los
Angeles, CA
Developmental immunology, immunotherapy for the
neonate with infection, diagnosis of immunodeficiency and
relevance to the development of allergy will be discussed.
Target Audience: Pediatricians who care for newborns,
including neonatologists dealing with premature, high-risk
newborns.
Overview
E.
Richard Stiehm, Mattel Children's Hospital at UCLA, Los
Angeles, CA
Transient and Congenital Immunodeficiencies of the
Newborn: Recognition and Management
David
B. Lewis, Stanford University Medical Center, Stanford, CA
Newborn Immunity as a Predictor for the Development
of Wheezing and Allergy
James
E. Gern, University of Wisconsin, Madison, WI
Immunologic Intervention in the Newborn: Relevance to
Newborn Infections
Harry
R. Hill, University of Utah School of Medicine, Salt Lake
City, UT
1:00pm–3:00pm
4652—Neonatal
Infectious Disease and Inflammation
PAS Original Science Abstracts -
Platform Session
3:15pm–5:15pm
4849—Neonatal
Infectious Disease
PAS Original Science Abstracts -
Platform Session
3:15pm–5:15pm
4890—AIDS/HIV
APA Special Interest Group
Chairs:
Nancy Hutton, nhutton@jhmi.edu;
and Lois Chandler Howland, lois.howland@umassmed.edu
HIV/AIDS is becoming increasingly prevalent among the
U.S. adolescent population due to “aging up” of
perinatally infected children and to adolescents becoming
infected through high-risk behaviors. Providing effective
health education to reduce HIV transmission risk, offering
accessible and confidential HIV counseling and screening
and identifying effective strategies to improve HIV
treatment adherence among adolescents are the key issues
to be addressed in the AIDS/HIV Special Interest Group
meeting this year. An interactive format will bring
clinicians and researchers together to provide the most
recent information and to discuss the most effective
approaches to these issues.
5:15pm–7:15pm
Poster
Session I
PAS Original Science Abstracts -
Poster Session
Neonatal Infectious Diseases:
4970—Coagulase Negative Staph
4971—Central Venous Catheters
4972—Antibiotic Usage
4973—Gram Negatives
4974—Candida
4975—Neonatal Sepsis and Pneumonia
4976—Neonatal Sepsis, Diagnosis
4977—Cytokines, Immunomodulation, Pathogenesis
Infectious Diseases:
4980—Herpesviruses
4981—Human Papillomavirus
4982—Respiratory Syncytial Virus (RSV)
4983—Human Metapneumovirus
4984—Influenza
4985—Miscellaneous Respiratory Viruses
4986—Miscellaneous Viruses
4987—HIV
Sunday, MAY 15
7:00am–8:00am
5053—Infectious
Diseases
PAS Meet the Professor Breakfast
Sarah S. Long, MCP Hahnemann University School of Medicine,
St. Christopher's Hospital for Children, Philadelphia, PA
This interactive session is designed to provide
trainees and junior faculty with insight and advice
concerning the pursuit of an academic career in pediatric
infectious diseases. Infectious diseases includes a wide
variety of career goals. Specific attention will be given
to describing approaches to obtaining the best possible
training to match individual goals—in clinical
infectious diseases, epidemiology, as well as in basic and
applied research. The discussion also will include
perspectives especially useful for junior faculty on
getting known, getting published and getting promoted.
Target Audience: Trainee, junior faculty.
8:00am–10:00am
5101—ARDS:
New Pathways and Treatments
PAS Topic Symposium
Chairs:
Steven H. Abman, University of Colorado School of
Medicine, Denver, CO; and Alan Jobe, Cincinnati Children's
Hospital Medical Center, Cincinnati, OH
Acute respiratory distress syndrome (ARDS) remains a
leading cause of morbidity and death in critically ill
neonates, infants and children. ARDS is associated with
diverse clinical disorders, including sepsis, trauma,
aspiration and infection and is characterized by lung
inflammation, non-hydrostatic pulmonary edema and poor
lung compliance. Recent advances in the basic pathobiology
of lung injury have led to new insights into the etiology
and potential therapeutic approaches toward ARDS. In
addition, recent clinical studies have examined
differences between adult and pediatric ARDS, genetic
susceptibility factors that may increase the risk for ARDS,
interactive cellular and physiologic mechanisms that cause
progressive lung injury and the role of different
strategies of mechanical ventilation that can adversely or
favorably determine the clinical outcomes of patients with
ARDS. This symposium includes leading experts in the field
of lung biology and critical care who will present state
of the art information on basic pathophysiologic
mechanisms of ARDS and new therapeutic approaches. These
integrated topics are of marked interest to intensivists,
neonatologists, pulmonologists, infectious disease and
basic scientists in the field of lung biology.
Target Audience: Scientists and clinicians interested
in basic mechanisms underlying the pathophysiology of
acute lung injury and clinical strategies in the
management of acute hypoxemic respiratory failure in
neonates, infants and children.
New Insights into ARDS
Michael
Matthay, University of California San Francisco Medical
School, San Francisco, CA
Mechanisms of Tissue Injury in Sepsis/ARDS
Hector
R. Wong, Cincinnati Children's Hospital Medical Center,
Cincinnati, OH
Role of Permissive Hypercapnea in Acute Lung Injury
Brian
Kavanagh, Hospital for Sick Children, Toronto, ON, Canada
Novel Ventilator Strategies in ARDS
John
H. Arnold, Children's Hospital, Boston, MA
8:00am–10:00am
5102—Community-Acquired
Staphylococcal Disease: New Twists for a Traditional
Pediatric Pathogen
PAS/PIDS Hot Topic
Chairs:
Stephen I. Pelton, Boston University School of Medicine,
Boston, MA; and Sheldon L. Kaplan, Baylor College of
Medicine, Houston, TX
Community-acquired, methicillin-resistant
Staphylococcal disease has been reported with increasing
frequency from multiple geographic locations in the United
States over the past several years. This symposium will
present current data on the epidemiology, molecular
genetics and clinical aspects of these evolving pathogens,
as well as on infection control practices that may be
useful for prevention.
Target Audience: Scientists and clinicians from the
following disciplines: pediatric infectious disease,
community pediatricians, pediatric ER and public health.
Community-Acquired Staphylococcal Disease: New Twists
for a Traditional Pediatric Pathogen
Stephen
I. Pelton, Boston University School of Medicine, Boston,
MA
Epidemiology of Community-Acquired, Methicillin-Resistant
Staphylococcus aureus
Daniel
B. Jernigan, Centers for Disease Control and Prevention,
Atlanta, GA
The Molecular Basis For Epidemic Community-Onset MRSA
Robert
S. Daum, The University of Chicago, Chicago, IL
Clinical Implications of Community-Acquired,
Methicillin-Resistant Staphylocccus aureus
Sheldon
L. Kaplan, Baylor College of Medicine, Houston, TX
Prevention and Control of Methicillin-Resistant
Staphylococcus aureus
Donald
A. Goldmann, Children's Hospital Boston, Boston, MA
Sponsored jointly by the Pediatric
Infectious Diseases Society and the Pediatric Academic
Societies
11:45am–1:45pm
Poster
Session II
PAS Original Science Abstracts -
Poster Session
Infectious Diseases:
5470—Inflammatory Mediators
5471—Fungal Infections
5472—Borrelia, Rickettsia, Ehrlichia
5473—Group A Streptococcus
5474—Meningitis
5475—Miscellaneous
5476—Staphylococcus aureus
5477—Pneumococcus
5478—Pertussis
5479—Tuberculosis
5480—Vaccines
2:00pm–4:00pm
5522—Update
on Human Milk Immunobiology and Infectious Disease: New
Insights and Current Controversies
PAS/PIDS/Milk Club Topic
Symposium
Chairs:
Mark R. Schleiss, University of Minnesota Medical School,
Minneapolis, MN; and Lawrence M. Gartner, Professor
Emeritus, University of Chicago, Chicago, IL
The importance of human milk feeding to reduce risk
of infectious disease in infants is undisputed among
pediatricians. Nevertheless, more data are needed about
the basic biology of human milk, particularly in relation
to specific health and developmental effects on term and
premature infants. There have recently been significant
advances in the understanding of the immunobiology of
breast milk, particularly with respect to the role of
oligosaccharides in protection against diarrheal disease,
and new insights into interrelationships between breast
milk and gut immune responses. In addition to presenting
these new research data, this session will also review
clinical controversies in breast feeding practice,
including issues of milk storage and the potential for
transmission of infectious pathogens, in particular
cytomegalovirus, via human milk. Areas of need for future
clinical and basic research will be emphasized.
Target Audience: Clinicians responsible for the care
of newborn infants, particularly premature infants;
neonatologists, gastroenterologists, infectious diseases
physicians and general pediatricians; and basic scientists
conducting research on human milk, secretory immunity or
gut immunity.
The Future of Breast Milk Research: What Do We Need
To Learn?
Lawrence
M. Gartner, Professor Emeritus, University of Chicago,
Chicago, IL
Human Milk Oligosaccharides and Their Role in
Protection Against Gastroenteritis
Ardythe
L. Morrow, Cincinnati Children's Hospital Medical Center,
Cincinnati, OH
Infectious Diseases and Human Milk: Does
Cytomegalovirus Pose a Risk to the Breast-fed Infant?
Mark
R. Schleiss, University of Minnesota Medical School,
Minneapolis, MN
Human Milk as a Carrier of Biochemical Responses to
the Newborn
W.
Allan Walker, Harvard Medical School, Boston, MA
Mother's Milk, Milk Banks and Preemies: Effects of
Pasteurization and Storage on Milk Nutrition and Biology
Richard
J. Schanler, Schneider Children's Hospital at North Shore,
North Shore University Hospital, Manhasset, NY
Human Milk Immunology: The Whole Is Greater Than the
Sum of Its Parts
Charles
Isaacs, New York State Institute for Basic Research,
Staten Island, NY
Discussion
Sponsored jointly by the Pediatric
Infectious Diseases Society, the Milk Club and the
Pediatric Academic Societies
2:00pm–4:00pm
5532—Epidemiology
Research II
PAS Original Science Abstracts -
Platform Session
2:00pm–4:00pm
5538—Pathogenesis,
Prevention and Treatment of Necrotizing Enterocolitis
PAS Original Science Abstracts -
Poster Symposium
4:15pm–6:15pm
5700—Clinical
Trial Registries: Challenges and Opportunities
PAS/PPC State of the Art Plenary
Chair:
Myron Genel, Chair, Public Policy Council and Professor
Emeritus of Pediatrics, Yale University School of
Medicine, New Haven, CT
Over the past year there has been a great deal of
attention in the medical literature and lay press to the
availability of data conducted by pharmaceutical firms,
particularly when that data reveals potential side effects
or fails to demonstrate significant benefit. The American
Medical Association's Council on Scientific Affairs has
recommended that the Department of Health and Human
Services establish a comprehensive registry for all
clinical trials and that results from these trials be
publicly available. The Council as well as the
International Committee of Medical Journal Editors(ICMJE)
has also recommended that institutional review boards
require registration of clinical trials and the ICMJE will
soon require registration as a precondition for
publication. Finally legislation has been introduced—The
Fair Access to Clinical Trials(FACT) Act—that would
codify these recommendations for all clinical trials
irrespective of sponsorship, perhaps through expansion on
the National Library of Medicine's ClinicalTrials.gov
website. This symposium, the 12th Annual Public Policy
Plenary organized by the Public Policy Council and the
Public Policy and Advocacy Committee of the Ambulatory
Pediatric Association, will explore the implications of
these proposals, particularly for pediatric investigation
and clinical practice, with a panel of international
authorities. Time has been set aside to allow meaningful
discussion involving the panel and audience.
Target Audience: Pediatric clinicians and clinical
investigators.
Overview
Myron
Genel, Chair, Public Policy Council and Professor Emeritus
of Pediatrics, Yale University School of Medicine, New
Haven, CT
Why We Need a Global, Unified System for Clinical
Trial Registration
Kay
Dickersin, Director, U.S. Cochrane Center and Professor
Community Health, Brown University, Providence, RI
Registering Clinical Trials—The Response from
Medical Journals
Christine
Laine, Deputy Editor, Annals of Internal Medicine and
Executive Secretary, International Committee of Medical
Journal Editors, Philadelphia, PA
ClinicalTrials.gov–For All and Open To All
Donald
Lindberg, Director, National Library of Medicine, NIH,
Bethesda, MD
Implications for Pediatric Research
David
J. Schonfeld, Chair, American Academy of Pediatrics
Committee on Research, Yale University School of Medicine,
New Haven, CT
Discussion. Panel & Audience
Sponsored jointly by the Public Policy
Council, the Public Policy Advocacy Committee of the
Ambulatory Pediatric Association and the Pediatric
Academic Societies
4:15pm–5:45pm
5701—Crossing
the Pediatric Quality Chasm
PAS State of the Art Plenary
Chair:
Thomas F. Boat, University of Cincinnati College of
Medicine, Cincinnati, OH
This state of the art plenary addresses the pediatric
dimension of the national movement in quality improvement
accelerated by the 2001 Institute of Medicine report,
"Crossing the Quality Chasm, A New Health System for
the 21st Century." The ability to understand, adopt
and determine the impact of quality improvement processes
is critical to academic pediatric health centers. To
sustain viability in the coming health care crisis, they
will have to demonstrate that their care is of the highest
quality, safety and reliability. The Plenary addresses
quality improvement: (1) as it relates to academic
pediatrics; (2) its current state of science and practice
in pediatrics; (3) how it is practically being applied in
an academic setting in the context of the missions of
patient care, research and education; and (4) training
implications. Presenters are recognized leaders in the
field.
Target Audience: Anyone involved in patient care in
an academic setting, particularly individuals with
administrative responsibilities (clinic/service heads,
division chiefs, chairs, etc.) or with research/teaching
interest in the area of quality improvement.
The Important Role of Quality Improvement in Academic
Pediatrics
Thomas
F. Boat, University of Cincinnati College of Medicine,
Cincinnati, OH
What Is the State of Quality Improvement in
Pediatrics?
Carole
M. Lannon, North Carolina Center for Children's Health
Care Improvement, Chapel Hill, NC
How To Integrate Research, Teaching and Quality of
Care Missions
Uma
R. Kotagal, University of Cincinnati College of Medicine,
Cincinnati, OH
Training and Maintaining the Pediatricians of the
21st Century—The Role of Quality Improvement
Paul
Miles, American Board of Pediatrics, Chapel Hill, NC
Discussion
4:15pm–5:45pm
5703—Stem
Cell Therapies: What's On the Horizon for Pediatrics and
Pediatric Diseases
PAS State of the Art Plenary
Chair:
Stuart Orkin, Dana Farber Cancer Institute, Boston, MA
Stem cell-based approaches hold great promise for
treating many of the tissue degenerative disorders that
afflict our aging population. This symposium will explore
the role of stem cell therapies in pediatric disorders due
to inborn errors of metabolism and other single-gene
defects. Furthermore, the symposium will discuss the
implications of new data indicating that fetal cells in
the maternal circulation can participate in maternal wound
repair, implying that the fetus may be able to “treat”
its mother.
Target Audience: Broad appeal for scientists and
clinicians interested in new therapeutic approaches based
on stem cell biology.
Stem Cell Therapy in Lysosomal Storage Disorders
Susan
L. Staba, University of Florida, Gainesville, FL
Liver Repopulation with Stem Cells
Markus
Grompe, Oregon Health & Science University, Portland,
OR
Summation and Perspectives
Stuart
H. Orkin, Dana Farber Cancer Institute, Boston, MA
Pregnancy-Associated Stem Cells: Does the Fetus
"Treat" Its Mother?
Diana
W. Bianchi, Tufts University School of Medicine, Floating
Hospital for Children, Boston, MA
6:15pm–7:15pm
5875A—Neonatal
Sepsis Club
Club
Hot Topics in Neonatal Meningitis
George H. McCracken
Contact:
David Kaufman, M.D.
University of Virginia Children's Medical Center
Phone: 434-924-9114
Email: davidkaufman@virginia.edu
Monday, MAY 16
8:00am–10:00am
6137—Infectious
Diseases
PAS Original Science Abstracts -
Platform Session
10:15am–12:00pm
6300—SPR
Presidential Plenary and Awards
SPR Presidential Plenary
Introduction
Lisa
M. Guay-Woodford, University of Alabama at Birmingham,
Birmingham, AL
Maureen Andrew Mentor Awardee
Edward
R.B. McCabe, Mattel Children's Hospital at UCLA, Los
Angeles, CA
Richard D. Rowe Awardee
Vidu
Garg, University of Texas Southwestern Medical School,
Dallas, TX
Richard D. Rowe Award Honorable Mention
Conrad
L. Epting, University of California, San Francisco
Stephanie Marie Ware, Cincinnati Children's Hospital
Medical Center, Cincinnati, OH
David G. Nathan Awardee
Mwe
Mwe Chao,
Douglas K. Richardson Awardee
Maureen
Hack, Case Western Reserve University, Cleveland, OH
Young Investigator Awardee
Anne
Marguerite Moon, University of Utah Health Sciences Center
SPR Distinguished Service Award
Samuel
Hawgood, University of California Medical Center, San
Francisco, CA
E. Mead Johnson Awardees
Elizabeth
C. Engle, Children's Hospital, Boston, MA
Gene Therapy for Inherited Lung Disease
Terence
R. Flotte, University of Florida, Gainesville, FL
SPR Presidential Address
Lisa
M. Guay-Woodford, University of Alabama at Birmingham,
Birmingham, AL
*The E. Mead Johnson Awards are supported
by an educational grant from Mead Johnson Nutritionals
10:15am–12:15pm
6355—Immunizations
Delivery
PAS Original Science Abstracts -
Poster Symposium
2:00pm–4:00pm
6600—Virus–Host
Interactions: Mechanisms Underlying Persistent Viral
Infections
PAS/PIDS Topic Symposium
Chairs:
Kenneth A. Alexander, Duke University Medical Center,
Durham, NC; and John Vanchiere, Baylor College of
Medicine, Houston, TX
In recent years it has become clear that traditional
concepts about immune response to and clearance of
pathogenic viruses are only part of the whole story.
Increasing numbers of viruses are now recognized to cause
persistent, low-level replication in the host, with
long-term adverse health consequences in both normal and
immune compromised hosts. These include viruses known to
establish latency, such as the herpes viruses, and viruses
that can cause persistent infection without a latent
state, such as hepatitis C virus and polyomaviruses. This
symposium will focus on virus–host interactions that
allow for establishment of latent or persistent infection
and the opportunities to exploit these interactions to
facilitate gene therapy.
Target Audience: Scientists and clinicians from the
following disciplines: pediatric infectious diseases,
general pediatricians, pediatric gastroenterologists,
pediatric hematology/oncology physicians.
Viral Persistence: Surveillance of the Iceberg from
Its Surface
John
A. Vanchiere, Baylor College of Medicine, Houston, TX
Unraveling the Molecular Mechanisms of Herpes Simplex
Virus Latency and Reactivation in the Nervous System
Nancy
M. Sawtell, Cincinnati Children's Hospital Medical Center,
Cincinnati, OH
Hepatitis C: Mechanisms Contributing to Chronic
Infection and Immune Evasion
Stanley
Lemon, University of Texas Medical Branch, Galveston, TX
Adenovirus Based Vectors as Tools to Understand Viral
Persistence
Andrea
Amalfitano, Duke University Medical Center, Durham, NC
Sponsored jointly by the Pediatric
Infectious Diseases Society and the Pediatric Academic
Societies
3:00pm–5:00pm
6700—Disorders
of Leukocyte Movement
PAS Topic Symposium
Chair:
Richard E. Stiehm, Mattel Children's Hospital at UCLA, Los
Angeles, CA
This symposium will focus on the importance of
leukocyte movement in infection and inflammation,
including basic mechanisms and abnormalities in several
rheumatic and immunodeficiency syndromes, including the
WHIM syndrome, the first described disorder of a chemokine
receptor mutation.
Target Audience: Immunologists, hematologists,
rheumatologists and basic scientists.
Introduction
E.
Richard Stiehm, Mattel Children's Hospital at UCLA, Los
Angeles, CA
Introduction to Cell Movement and Abnormalities in
Rheumatic Syndromes
Anna
Huttenlocher, University of Wisconsin, Madison, WI
Chemokines, Chemokine Receptors and the Defect in the
Warts-Hypogammaglobulinemia-Infection-Myelokathexis (WHIM)
Syndrome
Virginia
Gulino, National Cancer Institute/NIH, Bethesda, MD
Leukocyte Adhesion Defects: Clinical and Laboratory
Correlates
Steven
M. Holland, National Institute of Allergy and Infectious
Disease/NIH, Bethesda, MD
3:00pm–5:00pm
6736—Placental
Biology
PAS Original Science Abstracts -
Poster Symposium
4:00pm–5:00pm
6790A—PIDS
Plotkin Award Lectureship
PIDS Award
The Pediatric Infectious Diseases Society (PIDS) has
established the Stanley A. Plotkin Lectureship in
Vaccinology to honor Dr. Plotkin, the Society's
"Founding Father." The lecture, which takes
place at the annual PIDS meeting, is sponsored by Sanofi
Pasteur. Dr. Plotkin was medical director at Sanofi
Pasteur and remains a medical and scientific advisor. Dr.
Plotkin was awarded with the inaugural lectureship in
2004.
Introduction
Ross
E. McKinney, Duke University Medical Center, Durham, NC
Smallpox, Polio, Can Measles be Far Behind?
Samuel
L. Katz, Duke University Medical Center, Durham, NC
Supported by an educational grant from
Sanofi Pasteur
5:00pm–6:00pm
6795A—PIDS
Business Meeting
PIDS Business Meeting
5:15pm–6:45pm
Poster
Session III
PAS Original Science Abstracts -
Poster Session
Adolescent Medicine:
6803—Sexually Transmitted Infections (STIs) and
Reproductive Health
General Pediatrics and Preventive
Pediatrics:
6823—Infectious Disease
Global Paediatric Research:
6830—Birth Asphyxia
Neonatology:
6875—Neonatal Infection/Inflammation
6:15pm–
6930A—PIDS
Annual Dinner and Awards Banquet
PIDS Dinner
Tuesday, MAY 17
8:00am–10:00am
7152—Clinical
Trials in Perinatal and Neonatal Medicine II
PAS Original Science Abstracts -
Platform Session
8:00am–10:00am
7155—General
Pediatrics III
PAS Original Science Abstracts -
Platform Session
8:00am–10:00am
7158—Mechanisms
of Childhood Lung Disease
PAS Original Science Abstracts -
Platform Session
10:15am–11:45am
7300—Children's
Health and the Federal Government: Research and Public
Health Policy
PAS State of the Art Plenary
Chairs:
Lisa Guay-Woodford, President, Society for Pediatric
Research; and Paul Young, Chair, PAS Program Committee
Elias A. Zerhouni, the Director of the NIH and Vice
Admiral Richard H. Carmona, the Surgeon General of the
United States, will provide PAS attendees with their views
of the critical issues related to pediatric research and
the health of our nation's children.
Target Audience: All attendees
Introduction
Paul
C. Young, University of Utah School of Medicine, Salt Lake
City, UT
Lisa M. Guay-Woodford, University of Alabama at
Birmingham, Birmingham, AL
The NIH Roadmap for Medical Research
Elias
A. Zerhouni, Director, National Institutes of Health,
Bethesda, MD
Promoting Health for U.S. Children and Their Families
Vice
Admiral Richard H. Carmona, Surgeon General of the United
States, Washington, DC
Discussion
7303—Pediatric Biopreparedness: Dual-Use Systems for Everyday
and Times of Trouble
PAS State of the Art Plenary
Chairs:
Michael W. Shannon, Children's Hospital Boston, Boston,
MA; and Kenneth D. Mandl, Children's Hospital Boston,
Boston, MA
Addressing the medical and public health consequences
of an emerging infection, a naturally occurring outbreak
or a bioterrorist attack requires well-developed
capabilities for detection, analysis and response. In the
context of national preparedness there has been heavy
investment to develop these capabilities, but only limited
attention has been paid to the unique needs of the
pediatric population. Further, the use of these systems
for every day problems as well as disasters is critical if
the efforts are to be sustainable.
A multidisciplinary faculty from the Center for
Biopreparedness at Children’s Hospital Boston will
present leading-edge research on (1) public health
informatics for the real-time epidemiology of outbreaks of
infectious disease among children, (2) approaches to
development and dissemination of principles of pediatric
bioterrorism response and (3) the dual use of
biopreparedness technology.
Target Audience: Scientists and clinicians involved
in bioterrorism preparedness efforts, emergency medicine,
public health and epidemiology.
Pediatric Biopreparedness
Michael
W. Shannon, Children's Hospital Boston, Boston, MA
Approaches to Development and Dissemination of
Principles of Pediatric Bioterrorism
Michael
W. Shannon, Children's Hospital Boston, Boston, MA
Real Time Epidemiology of Outbreaks of Infectious
Disease Among Children
Ben
Y. Reis, Children's Hospital Boston, Boston, MA
Dual Use of Real-Time Outbreak Detection Technology
Kenneth
D. Mandl, Children's Hospital Boston, Boston, MA
Discussion
|
